Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure and function in gene patenting

R S Eisenberg1

  • 1University of Michigan Law School, Ann Arbor 48104, USA. rse@umich.edu

Nature Genetics
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Energetics of discrete selectivity bands and mutation-induced transitions in the calcium-sodium ion channels family.

Physical review. E, Statistical, nonlinear, and soft matter physics·2013
Same author

Multi-ion conduction bands in a simple model of calcium ion channels.

Physical biology·2013
Same author

The role of the electrochemical gradient in determining potassium fluxes in frog striated muscle.

The Journal of general physiology·2009
Same author

Singular perturbation analysis of the steady-state Poisson-Nernst-Planck system: Applications to ion channels.

European journal of applied mathematics·2009
Same author

Self-consistent analytic solution for the current and the access resistance in open ion channels.

Physical review. E, Statistical, nonlinear, and soft matter physics·2009
Same author

Look at biological systems through an engineer's eyes.

Nature·2007
Same journal

Mutational scanning reveals substrate-assisted autoregulation of the WNT destruction complex.

Nature genetics·2026
Same journal

Spatial transcriptomic analyses highlight distinct erythroid niches in mice and humans.

Nature genetics·2026
Same journal

Building up pangenome analysis block by block.

Nature genetics·2026
Same journal

Mutations in splicing factor gene U2AF1 rescue defective oncogene splicing in KRAS-mutant cancers.

Nature genetics·2026
Same journal

Assessing the effect of immune surveillance on clonal expansions in the blood.

Nature genetics·2026
Same journal

Improved heritability partitioning and enrichment analyses using summary statistics with graphREML.

Nature genetics·2026
See all related articles

The US patent system views DNA as chemicals, aiding new sequence patents. However, this chemical-centric approach may hinder patents for discovering gene functions and disease links, as seen with leptin receptor gene patents.

Area of Science:

  • Biotechnology Law
  • Intellectual Property
  • Molecular Biology

Background:

  • The United States patent system classifies DNA sequences as chemical compounds for patentability assessments.
  • This legal framework has historically supported the patenting of novel DNA sequences.

Purpose of the Study:

  • To analyze the implications of patenting DNA sequences as chemical compounds.
  • To examine potential disadvantages for gene function and disease relevance discovery.
  • To use the leptin receptor gene patent controversy as a case study.

Main Methods:

  • Legal analysis of patent doctrines applied to chemical compounds.
  • Case study examination of the leptin receptor gene patent dispute.
  • Comparative analysis of patenting strategies for novel sequences versus functional discoveries.

Related Experiment Videos

Main Results:

  • The chemical compound approach benefits patenting of unidentified DNA sequences.
  • This approach may present challenges for patenting the biological functions and disease relevance of known genes.
  • The leptin receptor case highlights conflicts in applying chemical patent law to gene discovery.

Conclusions:

  • Current patent law's chemical-based treatment of DNA may create barriers for biological function and disease relevance patents.
  • Re-evaluation of patent doctrines may be necessary to accommodate advancements in gene discovery and functional genomics.
  • The leptin receptor patent controversy underscores the need for clarity in DNA-related intellectual property law.